Literature DB >> 9762360

The physiological role of glucokinase binding and translocation in hepatocytes.

L Agius1.   

Abstract

The compartmentation of glucokinase in the hepatocyte is regulated by the extracellular glucose concentration and by substrates that alter the concentration of fructose 1-phosphate in the hepatocyte. At low glucose concentrations, that mimic the fasted state, glucokinase is sequestered in an inactive state bound to the 68 kDa regulatory protein in the nucleus. In these conditions the rate of glucose phosphorylation is less than 15% of the total glucokinase activity. An increase in extracellular glucose concentration, within the range occurring in the portal vein in the absorptive state, or low concentrations of fructose or sorbitol (precursors of fructose 1-phosphate), cause the translocation of glucokinase from the nucleus to the cytoplasm and this is associated with a corresponding increase in glucose phosphorylation. The effect of glucose on translocation is mimicked by mannose which is also phosphorylated by glucokinase as well as by competitive inhibitors of glucokinase (mannoheptulose and 5-thioglucose) which are not phosphorylated. Various lines of evidence suggest that the action of these analogues is most likely due to binding to an allosteric or non-catalytic site. The saturation curve of glucose phosphorylation in intact hepatocytes is sigmoidal with an S0.5 of approximately 20 mM and a Hill coefficient approximately 2. This saturation curve can be explained by the activity of glucokinase in the cytoplasmic compartment. Translocation of glucokinase from the nucleus to the cytoplasm in response to precursors of fructose 1-phosphate (which cause dissociation of glucokinase from the regulatory protein) is associated with stimulation of glucose phosphorylation, glycolysis and glycogen synthesis. Using Metabolic Control Analysis to determine the Control Coefficient (Control Strength) of cytoplasmic (free) glucokinase on glucose metabolism it can be shown that the free glucokinase activity has a very high control strength on glycogen synthesis (CFGKJ > 1), indicating a major role of translocation of glucokinase in the control of hepatic glycogen synthesis. Overexpression of glucokinase in hepatocytes by adenovirus-mediated glucokinase overexpression is associated with a marked increase in glycogen synthesis. The relation between glycogen synthesis and enzyme overexpression is sigmoidal with an enzyme concentration causing half-saturation (S0.5) in the physiological range. The high Control Coefficient of glucokinase on hepatic glycogen synthesis explains the abnormalities of hepatic glycogen synthesis in patients with a single mutant allele of the glucokinase gene (Maturity Onset Diabetes of the Young, type 2).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762360     DOI: 10.1016/s0065-2571(97)00001-0

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  11 in total

1.  Occurrence of paradoxical or sustained control by an enzyme when overexpressed: necessary conditions and experimental evidence with regard to hepatic glucokinase.

Authors:  P De Atauri; L Acerenza; B N Kholodenko; N De La Iglesia; J J Guinovart; L Agius; M Cascante
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.

Authors:  Hana Alkhalidy; Will Moore; Aihua Wang; Jing Luo; Ryan P McMillan; Yao Wang; Wei Zhen; Matthew W Hulver; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-01       Impact factor: 6.048

3.  Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.

Authors:  Kiichiro Ueta; Tracy P O'Brien; Gregory A McCoy; Kuikwon Kim; Erin C Healey; Tiffany D Farmer; E Patrick Donahue; Audree B Condren; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-08       Impact factor: 4.310

4.  Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites.

Authors:  L Agius; M Stubbs
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

5.  Lack of glucokinase regulatory protein expression may contribute to low glucokinase activity in feline liver.

Authors:  Erin K Hiskett; Orn-Usa Suwitheechon; Sara Lindbloom-Hawley; Daniel L Boyle; Thomas Schermerhorn
Journal:  Vet Res Commun       Date:  2008-09-09       Impact factor: 2.459

Review 6.  Assessing the potential of glucokinase activators in diabetes therapy.

Authors:  Franz M Matschinsky
Journal:  Nat Rev Drug Discov       Date:  2009-04-17       Impact factor: 84.694

7.  Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.

Authors:  Jung Min Choi; Moon-Hyeong Seo; Hyun-Ho Kyeong; Eunkyung Kim; Hak-Sung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

8.  Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions.

Authors:  M C T Fyfe; J R White; A Taylor; R Chatfield; E Wargent; R L Printz; T Sulpice; J G McCormack; M J Procter; C Reynet; P S Widdowson; P Wong-Kai-In
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

9.  Glucokinase activators for diabetes therapy: May 2010 status report.

Authors:  Franz M Matschinsky; Bogumil Zelent; Nicolai Doliba; Changhong Li; Jane M Vanderkooi; Ali Naji; Ramakanth Sarabu; Joseph Grimsby
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

Review 10.  Normal glucose metabolism in carnivores overlaps with diabetes pathology in non-carnivores.

Authors:  Thomas Schermerhorn
Journal:  Front Endocrinol (Lausanne)       Date:  2013-12-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.